Hexagon Nutrition Limited has officially launched its mainboard IPO and is offering shares for subscription at ₹42–₹45. The issue, which started on June 5, 2026, has received a big response from retail investors and market observers. Early subscription data and grey-market activity indicate positive prospects for the company with a positive IPO performance.
The IPO consists of an Offer for Sale (OFS) of about 3.08 crore equity shares which is almost ₹139 crore. There is no fresh issue component and the money will go to existing shareholders as per the company’s strategy. The minimum lot size for retail investors is 333 shares and will cost ₹14,985 in the upper price band. Anchor investors have already committed funds which means they are confident in the company’s fundamentals.
Hexagon Nutrition has a very strong reputation in clinical nutrition and wellness today. Pentasure, Obesigo, and Pediagold are the company's leading brands, which are very different health care brands and offer therapeutic nutrition and fortified foods. It is a market player in more than 75 countries, as it has a very integrated business model and products are constantly being invented.
Market analysts say the IPO is happening just when investors are hungry for health and wellness companies. Hexagon Nutrition shares have a GMP of ₹10–₹12, and could be priced at ₹55–₹57 per share. This represents a 22–26% gain over the issue price, but GMP is just speculation and is not an indicator of performance.
On Day one, subscription data showed a lot of retail investors were interested in signing up for it, and investment from institutional investors is expected to be more active later in the process. Brokerage firms have also cited Hexagon Nutrition being the top nutrition company and having a great brand portfolio and growth potential as one of the reasons that might make them subscribe. But risks that are still to be taken into account are that there is no fresh capital and reliance on existing product lines.
Finally, Hexagon Nutrition’s IPO has generated a lot of attention in the market as the product strength of the company is being recognized by investors which is a very strong indicator of health-oriented businesses. The company is in high demand and a good grey-market trend so it has a good chance of a listing even if in the long term it is going to grow and expand the worldwide reach of its company.
Comments
Please to leave a comment on this article.